March 19, 2021
Greater Disability Tied to Worse COVID-19 Severity in MS Patients
FRIDAY, March 19, 2021 (HealthDay News) — Ambulatory disability and older age are associated with worse clinical severity of COVID-19, including death, among patients with multiple sclerosis (MS), according to a study published online March 19 in JAMA Neurology. Amber Salter, Ph.D., from the Washington University School of Medicine in St. Louis, and colleagues examined...
ENDO: Common Meds Interfere With TFTs in Older Adults on Thyroid Hormone
FRIDAY, March 19, 2021 (HealthDay News) — Almost one-third of adults aged 65 years and older on thyroid hormone replacement also take medications that commonly interfere with thyroid function tests, according to a study presented at the annual meeting of The Endocrine Society, held virtually from March 20 to 23. Rachel Beeson, M.D., from the...
ENDO: Rates of Drug Treatment for Osteoporosis Low in the US
FRIDAY, March 19, 2021 (HealthDay News) — An analysis of U.S. claims data from a private insurance database indicates that many patients who are eligible for drug therapy of osteoporosis are not receiving prescriptions for bone-directed medications, according to a study presented at the annual meeting of The Endocrine Society, held virtually from March 20...
Rhinology Clinical Trials Exhibit Decade-Long Disparities
In this study, published in The Laryngoscope, a team of researchers attempted to analyze the demographic characteristics of patients who participated in chronic rhinosinusitis clinical trials. The study’s goal was to identify discrepancies between the general population and the groups of individuals who participated in these trials. Because many clinical trials deviate from the general population,...
Factors in Pediatric Oncology Clinical Trial Enrollment
In this study, published in Pediatric Blood & Cancer, a team of researchers sought to understand the barriers that make it more difficult for children with cancer to be enrolled in clinical trials. They note that there are many different known barriers to clinical trial enrollment, varying widely from research infrastructure to a more general...